Navigation Links
Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
Date:12/7/2009

PINE BROOK, N.J., Dec. 7 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, announced today that recent animal efficacy and human safety data from the Company's Anthim® anthrax anti-toxin program were presented at the Biomedical Advanced Research and Development Authority (BARDA) Industry Day conference, December 4, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090420/NY01624LOGO )

In a podium presentation entitled "Advanced Development of Anthim® (ETI-204), a Highly-Effective Monoclonal Antibody for Treatment of Inhalational Anthrax: results of recent safety and efficacy studies," Dr. Leslie Casey, Vice President of Research, presented data from rabbit and primate treatment studies as well as clinical safety studies highlighting the therapeutic potential for Anthim in the treatment of anthrax disease. Using an established non-human primate treatment model, up to 79% of animals treated with a single, intravenous dose of Anthim at the onset of symptoms survived a lethal inhalational challenge with anthrax spores. All animals in this study were bacteremic at time of Anthim treatment.

The Company also reported the results of a previously conducted rabbit treatment study. A single dose of Anthim provided up to 94% survival when administered to rabbits after symptoms of disease were present. The results of these two studies are consistent with previously conducted rabbit and primate studies using Anthim and continue to show the dramatic increase in survival that Anthim can provide.

In a separate dose-escalating human clinical safety study, preliminary results show that Anthim continues to be safe and well-tolerated at doses at or above the anticipated efficacious
'/>"/>

SOURCE Elusys Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
2. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
3. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
4. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
5. Paloma Pharmaceuticals Presents at the AACR-NCI-EORTC International Conference Molecular Targets and Cancer Therapeutics
6. Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media
7. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting
9. Dr. Brad Vince, with Vince and Associates Clinical Research, Presents at the Exploratory Development World Congress 2009
10. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
11. Dr. Julian Henley MD Presents BioMatrix Lift
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , November 26, 2014 A ... of the organ protrudes through the wall of a weak ... area at birth are some of the causes of hernias. ... hiatal, femoral, and incisional. An inguinal hernia is when part ... umbilical hernia is found in the area of the umbilicus. ...
(Date:11/26/2014)...  CARsgen, a leader in the development of Chimeric ... variety of cancers, today announced the completion of a ... China -based healthcare private equity fund.   ... development of new therapeutics for liver, lung, stomach and ... Shanghai Renji Hospital, the company plans to initiate clinical ...
(Date:11/26/2014)... The medical magnetic resonance imaging (MRI) ... with world market revenues for 2013 at $5.1 ... types of medical imaging have led to improvements ... conditions in children and adults, each imaging procedure ... Medical Imaging Markets , analyzes the current and ...
Breaking Medicine Technology:Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... Meeting of the Heart Failure Society of America (HFSA) will ... recent studies relating to heart failure. Dr. D.J. ... a recent study of heart failure patients who are hospitalized ... the heart, and the heart is unable to manage the ...
... the following update for its range of advanced wound care ... regulatory approvals and product listings, Innocoll has added six more ... and spray formats that are available for commercialization in the ... Zealand. These products include:   CollaCare®, a ...
Cached Medicine Technology:Studying Fluid Overflow in Patients With Devices 2Studying Fluid Overflow in Patients With Devices 3Innocoll Provides an Update on its Range of Advanced Wound Care and Related Collagen-based Products 2
(Date:11/28/2014)... PreDiabetes Centers , a ... employees learn their risk for type 2 diabetes ... a local school in partnership with the American ... , As the Presenting Sponsor for the ... is co-hosting diabetes-prevention presentations at Austin-area companies with ...
(Date:11/28/2014)... November 28, 2014 Mabel’s Labels ... kids lose® and an award-winning company established by four ... Cynthia Esp, and Tricia Mumby have been honored with ... recognized with the PROFIT Award for Excellence in Entrepreneurship. ... Esp, and Tricia Mumby) accepted the award on behalf ...
(Date:11/28/2014)... UniWigs.com, a leader in the wig industry, has announced a ... This promotion features: , > 400 pieces of ... off (no coupon code needed), > 10% off ... over $49 , Visit http://www.uniwigs.com for more details , ... Dec. 1st and the first 100 shoppers each day will receive ...
(Date:11/28/2014)... 28, 2014 "Most of my life, I ... use crutches," said an inventor from Findlay, Ohio. "I thought ... to support my foot, which inspired me to invent this ... a convenient way to support an injured foot. The sling ... eliminates the need for crutches. The design redistributes weight so ...
(Date:11/28/2014)... NEW ALBANY, IN (PRWEB) November 28, 2014 ... of Americans were already preparing for the Christmas shopping season. ... the best deals on Black Friday, the biggest retail shopping ... the latest gadget or electronic device, New Albany dentist ... gift options that can improve oral health and literally brighten ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 2Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 3Health News:New Albany Dentist Offers Gift Ideas That Can Improve Oral Health 4
... celecoxib, known by its brand name Celebrex, can help prevent ... rectum and small intestine of children with an inheritable genetic ... rare but devastating disease, polyps begin forming in patients as ... hundreds or even thousands. The disease carries a 100-percent ...
... ... Programs, will unveil the Center for Biotechnology Education on Thursday, May 13, at ... the Montgomery County campus, 9601 Medical Center Drive in Rockville. , ... (PRWEB) May 13, 2010 -- The Johns Hopkins ...
... explanation for the persistent ability of melanoma cells to self-renew, ... of skin cancer. The concept of the "dynamic stemness" of ... tumor cells and cancer stem cells. The researchers write ... thatcontrary to other published reportsmelanoma does not appear to ...
... deletion syndrome (also known as DiGeorge syndrome) is ... an estimated incidence of at least one in ... severity but a multisystem impact, with symptoms that ... abnormalities, cleft palate, gastrointestinal problems, and neuropsychiatric abnormalities. ...
... ... Fellowship , ... May 12, 2010 -- University of Massachusetts Boston Chancellor J. Keith Motley today ... to fight against the HIV/AIDS epidemic, has been chosen as the recipient of the 2010 ...
... cells , THURSDAY, May 13 (HealthDay News) -- Researchers have ... cells in the laboratory that are similar to inner-ear cells ... , The cells in the inner ear have hair-like projections, ... are converted into a signal that can be interpreted in ...
Cached Medicine News:Health News:Johns Hopkins to Unveil Center for Biotechnology Education 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 3Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 2Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 3Health News:Without this protein, embryonic development halts 2Health News:Vietnamese Student Named UMass Boston JFK Award Winner 2Health News:Vietnamese Student Named UMass Boston JFK Award Winner 3Health News:Vietnamese Student Named UMass Boston JFK Award Winner 4Health News:Effort to Cure Some Types of Hearing Loss Gets Big Boost 2
Px2 thermal Cycler chassis (requires block). Multiple interchangeable blocks. Gradient capability. Adjustable height heated lid. Outstanding uniformity. Advanced control algorithms for reduced r...
... The Gene Cycler unit is an inexpensive personal ... for the PCR process. Lightweight, with a small ... almost anywhere, including the researcher's desk. , The ... researchers who do not have access to a ...
... Tetrad™ thermal cycler expands the envelope of ... cyler. It has four times the capacity ... providing very high throughput for laboratories that ... sequencing or diagnostic labs. Four blocks, ...
... Biosystems has designed its 60-well, 0.5 mL ... PCR applications (both DNA and RNA). The ... Frame ensure oil-free operation in the 0.5 ... the 0.5 mL GeneAmp PCR System 9700 ...
Medicine Products: